AnalystsKevin KedraKevin Kedra's Stock Forecasts
AnalystsKevin Kedra
Sectors:
Analyst Ranking
Bottom 15%
#4725 out of 5510 analysts
Average Return
-66.01%
Win Rate
33%1 out of 3
Risk vs Reward
Poor
Good
Kevin Kedra's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Assertio Holdings IncASRT | +40.16% | $36.60 | $51.30 | 2021-04-09 - 2022-04-08 | Strong Buy |
Kevin Kedra Analyst Color
Get additional color on Kevin Kedra's coverage of popular stocks
Kevin Kedra's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Elanco Animal Health IncELAN | 2 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Assertio Holdings IncASRT | 1 | Strong Buy | N/A | N/A | Upgrades | 5 years ago |
Zoetis IncZTS | 1 | Hold | N/A | N/A | Downgrades | 6 years ago |
Tetraphase Pharmaceuticals IncTTPH | 2 | Strong Sell | N/A | N/A | Downgrades | 6 years ago |
Phibro Animal Health CorpPAHC | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Lexicon Pharmaceuticals IncLXRX | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.